REAL-WORLD DATA (RWD) / REAL-WORD EVIDENCE (RWE) INSIGHTS
-
HTA, Digital Twins, And Building Clinical Tech That Lasts
ISPOR CEO Rob Abbott on HTA-integrated trial design, digital twin evidence gaps, SaMD’s continuous update problem, and the one change he’d mandate for clinical tech.
-
Real-World Evidence And Wearables Are Reshaping Trial Tech
ISPOR’s Rob Abbott on why RWE moved to number two in the 2026-2027 HEOR Trends Report, and what wearables, data fragmentation, and HARPER+ mean for clinical platforms.
RWD/RWE RESOURCES
-
CDW: An Evolving Product Category Speeds Access To Quality Data
Explore how exponential increases in third-party patient data have catalyzed the emergence of the clinical data workbench, representing a pivotal advancement in the evolving field of data management.
-
8 Key Applications Of Real-World Data In Multiple Myeloma Therapy Development
Explore how therapeutic area (TA) datasets can be leveraged to address the challenges multiple myeloma (MM) presents in the field of hematologic malignancies.
-
Readying Your Clinical Trial For Linkage With Real-World Data
Discover why the near ubiquity of real-world data (RWD) sources has prompted sponsors to consider RWD’s role in study programs and regulatory bodies to issue guidance on their use in clinical development.
-
Pitfalls And Possibilities: EHRs To RWD Via EDC
Consider DIA GCP & QA Community Chair Terry Katz’s perspective on repurposing and analyzing EHR data for clinical research.
-
How Small And Mid-Sized Biopharmaceutical Companies Can Easily Achieve Digital Innovation For Their Clinical Data
Discover how forward- thinking life science companies are defining their vision and looking for like-minded partners to execute information technology.
-
Mental Health Apps: Regulation And Validation Are Needed
Explore a proposed digital ecosystem that would balance rigorous validation with the urgent need for accessible mental health solutions, transforming the landscape into a resource for global well-being.
-
2024 MedTech Regulatory Updates: 4 Areas Of Interest
In 2024, McKinsey's projections foresee a promising year for the MedTech industry, driven by innovation but shadowed by regulatory uncertainty.